JPMorgan Keeps Stryker at Overweight, Cuts Price Target to $340
JPMorgan lowered its Stryker price target to $340 from $350 while maintaining its Overweight rating.
Story updates
12:19:14 AM UTC
SquawkNews
Stryker Price Target Cut to $340.00/Share From $350.00 by JP Morgan